Document is current
Any future updates will be listed below
-
Authors
Apolónio, Joana Dias
Dias, João S.
Fernandes, Mónica Teotónio
Komosa, Martin
Lipman, Tatiana
Zhang, Cindy H.
Leão, Ricardo
Lee, Donghyun
Nunes, Nuno Miguel
Maia, Ana-Teresa
Morera, José L.
Vicioso, Luis
Tabori, Uri
Castelo-Branco, Pedro
-
Funding
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (PD/BD/105899/2014, UID/BIM/04773/2013 CBMR 1334)
The Canadian Institutes of Health Research (MOP-137899, MOP-137899)
Canadian Cancer Society Research Institute
Maratona da Saúde
Liga Portuguesa Contra o Cancro
- License Information
-
More Information
Article History
Received: 23 April 2022
Accepted: 2 December 2022
First Online: 18 December 2022
Declarations
:
: All the breast cancer tissue samples and patients’ clinical data were retrospectively collected upon consent according to the Ethics Boards of the Centro Hospitalar Universitário do Algarve (CHUAlgarve, Hospital de Faro, Portugal). Healthy breast tissues derived from women submitted to reduction mammoplasty for reasons not related to cancer were included as normal controls (<i>n</i> = 26) [CitationRef removed]. Samples were collected with the approval from the Addenbrooke’s Hospital (Cambridge, UK) Local Research Ethics Committee (REC reference 06/Q0108/221).
: Not applicable.
: The authors declare that they have no competing interests.
